Table 2. Bronchoscopic findings of patients and bronchoscopic procedures.
| Bronchoscopical treatment group (n: 23) | Surgical treatment group (n: 19) | p value | |
|---|---|---|---|
| Flexible bronchoscopy number | 3 (IQR: 5) (0–24) | 1 (IQR: 2) (0–13) | 0.02 |
| Rigid bronchoscopy number | 3 (IQR: 2) (1–15) | 2 (IQR: 1) (1–13) | 0.03 |
| Obstruction ratio | 80.00 ± 2.99 (30–95) | 79.47 ± 8.95 (60–90) | 0.431 |
| Segment length | 2.07 ± 0.31 (0.8–7) | 1.98 ± 0.81 (1.0–3.7) | 0.560 |
| Malaise (%) | 7 (30.4) | 1 (5.3) | 0.03 |
| Distance to vocal cords | 2.80 ± 0.32 (1–6.5) | 3.61 ± 1.95 (2–9) | 0.133 |
| Cryotherapy (%) | 8 (34.8) | 2 (10.5)* | 0.059 |
| Diode laser (%) | 1 (4.3) | 1 (5.3) | 0.893 |
| Dilatation number | 2.09 ± 0.37 (0–8) | 1.63 ± 0.23 (1–5) | 0.462 |
*Cryotherapy; a patient who had undergone restenosis and underwent covered self-expandable metallic Y stenting and a patient who developed with atelectasis due to postoperative retention of secretion. IQR: interquartile range